Gregory P. Dubé - Concepedia

Author

Gregory P. Dubé

Eli Lilly (United States)

Also Known As

G P Dubé, G. DUBE, G. Dube, G. P. DUBE, G. P. Dube, G. P. Dubé, G.P. Dube, G.P. Dubé, Geneviève Dubé, Gregory Dube

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of British Columbia University of Cincinnati Medical Center Erasmus MC St. Paul's Hospital

About

Gregory P. Dubé is an author at Eli Lilly (United States) specializing in physiology, medicine, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	586
2	Biochemistry	3	3	72
3	Health Sciences	2	2	136
4	Biomedical Engineering	1	1	31
5	Cell Biology	1	1	19

Gregory P. Dubé

Publications

Citations

H-Index

Page 1

	Year	Citations
Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem A. Depover, Mohammed A. Matlib, S.W. Lee, Biochemical and Biophysical Research Communications Coronary ArteriesMolecular PharmacologyParadoxical StimulationCardiovascular DiseaseMedicine	1982	158
Hepatic over-expression of peroxisome proliferator activated receptor γ2 in the ob/ob mouse model of non‐insulin dependent diabetes mellitus Roshanak Rahimian, Esther Masih‐Khan, Maggie Lo, Molecular and Cellular Biochemistry	2001	119
Influence of Type II Diabetes on Arterial Tone and Endothelial Function in Murine Mesenteric Resistance Arteries Guy Lagaud, Esther Masih‐Khan, C. van Breemen, Journal of Vascular Research HypertensionImmunologyEndothelial FunctionType IiInsulin Signaling	2001	98
Estrogen and Selective Estrogen Receptor Modulator LY117018 Enhance Release of Nitric Oxide in Rat Aorta Roshanak Rahimian, Ismail Laher, Gregory P. Dubé, Journal of Pharmacology and Experimental Therapeutics	1997	77
A 31P-NMR study of some metabolic and functional effects of the inotropic agents epinephrine and ouabain, and the ionophore R02-2985 (X537A) in the isolated, perfused rat heart Paul M. Matthews, S. R. Williams, Austin M. Seymour, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Molecular PharmacologyMedicinePhysiologyPerfused Rat HeartNeuropharmacology	1982	73
Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: Implications in the treatment of restenosis after angioplasty Jai Singh, Kimberly J. Rothfuss, Todd R. Wiernicki, Journal of the American College of Cardiology AngiogenesisMedicineVascular PharmacologyPhysiologyVascular Adaptation	1994	51
Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression Roshanak Rahimian, Gregory P. Dubé, Warda Toma, European Journal of Pharmacology InflammationAnti-inflammatoryCardiovascular DiseaseMedicinePhysiology	2002	51
Effects of a Novel Calcium Channel Agonist Dihydropyridine Analogue, Bay k 8644, on Pig Coronary Artery Gregory P. Dubé, Yung Hong Baik, Arnold Schwartz Journal of Cardiovascular Pharmacology	1985	48
Pharmacological inhibition of<i>S</i>-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo Qiumei Chen, Richard E. Sievers, Mónika Varga, Journal of Applied Physiology Nitric OxideGsnor InhibitionPharmacological InhibitionRedox BiologyBlood Pressure	2013	48
Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD Patrick W. Serruys, Pascal Vranckx, Ton Slagboom, EuroIntervention	2008	41

Page 1